Delivery Order SPE2DB24D2018-SPE2DB25FWWM7
- Not listed
- The Defense Logistics Agency awarded a $14,879.31 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Gemtesa 75 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 16, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $16,427.01 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Gemtesa 75 mg tablets (90 count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 26, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $57,339.96 on September 5, 2025, for the supply of Gemtesa 75 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by September 8, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,310.02 on August 18, 2025, for the supply of Gemtesa 75 mg tablets (90-count units). This competitive, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Gemtesa 75 mg tablets (30-count packages) with a contract ceiling value of $4,316.81. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement. The order is to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order...
- The Defense Logistics Agency awarded a $115,979.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Gemtesa 75 mg tablets (90-count units), with an ultimate completion date of August 19, 2025. This non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) valued at $6,194.63. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical product will be performed in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) at a ceiling value of $2,378.33. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on August 29, 2025, with performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $7,642.01 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Gemtesa 75 mg tablets (90-count package) with completion targeted for September 10, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a $9,060.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Gemtesa 75 mg tablets (90-count units). The contract, which is a child order under AmerisourceBergen's larger pharmaceutical supply agreement, will be performed at the contractor's Conshohocken, Pennsylvania location with an ultimate completion date of September 8, 2025. This delivery order was competitively awarded with no set-aside designation,...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWWM7Delivery Order
The Defense Logistics Agency awarded a $38.4K delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Gemtesa 75 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99M through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated substantial capability in fulfilling federal medical procurement requirements through its extensive portfolio of contracts with the Defense Logistics Agency. The company supplies a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. As a critical vendor in the federal medical supply chain, AmerisourceBergen consistently executes competitively awarded delivery orders with firm fixed pricing, showcasing its ability to meet diverse federal healthcare procurement needs at various transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.4k | 9/2/25 |